Previous Article | Next Article 
Applied and Environmental Microbiology, February 2006, p. 1696-1699, Vol. 72, No. 2
0099-2240/06/$08.00+0 doi:10.1128/AEM.72.2.1696-1699.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Probing In Vivo Promoter Activities in Mycoplasma pneumoniae: a System for Generation of Single-Copy Reporter Constructs
Sven Halbedel and
Jörg Stülke*
Department of General Microbiology, Institute of Microbiology and Genetics, Georg-August University Göttingen, Grisebachstr. 8, D-37077 Göttingen, Germany
Received 12 September 2005/
Accepted 8 December 2005

ABSTRACT
The nucleotide sequences that control transcription initiation
and regulation in
Mycoplasma pneumoniae are poorly understood.
In this work, we developed a
lacZ-based reporter plasmid that
can be used to integrate fusions of promoter fragments to a
promoterless
lacZ gene into the chromosome of
M. pneumoniae.

INTRODUCTION
Mycoplasma pneumoniae is a human pathogen. The bacteria live
on mucosal surfaces of the respiratory tract and cause diseases
such as mild pneumonia and tracheobronchitis. In addition, some
nonrespiratory complications affecting the skin, mucosa, the
central nervous system, the heart, and other organs were reported
(
14,
18,
24). During the last few years,
M. pneumoniae and related
cell wall-less bacteria of the class
Mollicutes have attracted
considerable scientific interest since these bacteria possess
one of the smallest genomes of any free-living organism known
so far (
9). The minimal genetic complement of
M. pneumoniae and its close relative,
M. genitalium, has prompted studies
to identify the essential gene set required for independent
life (
5,
10). Moreover, the molecular details of the interaction
of
M. pneumoniae with the host tissues that lead to pathogenesis
are far from being understood. Similarly, not much is known
about gene expression in
M. pneumoniae. A few global studies
of gene expression in
M. pneumoniae have been reported (
15,
21,
23,
28). In good agreement with the life of
M. pneumoniae in a rather constant environment is the small number of regulatory
proteins encoded by the genomes of these bacteria. While the
transcription of some individual genes was studied in
M. pneumoniae (
1,
6,
11,
12,
27), nothing is known of regulatory mechanisms
in these bacteria.
The molecular analysis of M. pneumoniae has been hampered by three problems. First, the genes of M. pneumoniae and related mollicutes use the UGA opal codon to incorporate tryptophan rather than as a stop codon as in the universal genetic code. This makes it difficult to express proteins from Mycoplasma spp. in heterologous hosts in order to make them available for biochemical analysis (3, 13). Recently, a method for the simultaneous replacement of multiple opal codons was developed and used for the expression of M. pneumoniae glycerol kinase in Escherichia coli (7). A second major problem is the lack of genetic systems that allow the efficient targeted generation of M. pneumoniae mutants. Therefore, genetic research with these bacteria depends on the use of mutant strains that have been isolated in conventional screens or even by chance (26, 29). Finally, transcription in M. pneumoniae can so far be studied by only RNA-based methods, such as transcriptome analyses, Northern blotting, reverse transcriptase PCR, or primer extension for the determination of 5' ends of transcripts (1, 6, 11, 12, 25, 27, 28). The molecular analysis of transcription regulatory mechanisms has so far not been possible due to the lack of appropriate reporter systems that can be used to study the activity of promoter fragments and their mutant derivatives in vivo. In this study, we report a system for the generation of fusions of M. pneumoniae promoters to a promoterless lacZ gene that can be integrated into the M. pneumoniae chromosome.

Construction of the M. pneumoniae reporter system.
Since no genetic system allowing the targeted integration of
DNA fragments into the
M. pneumoniae chromosome is available,
we made use of a derivative of Tn
4001 (
8), which lacks the transposase
gene (mini-Tn
4001). The mini-Tn
4001 used here contains an origin
of replication that functions in
E. coli but not in
M. pneumoniae and a
aac-aphD gentamicin resistance gene which can be used
to select for gentamicin or kanamycin resistance in
M. pneumoniae or
E. coli, respectively (
22). Tn
4001 is known to insert randomly
into the chromosome of
M. pneumoniae (
10). The mini-Tn
4001,
together with the
tnp gene encoding transposase, was present
on plasmid pMT85 (
30). As the reporter, we selected the
lacZ gene of
E. coli encoding ß-galactosidase, which is
one of the most popular reporter enzymes, due to the possibility
of getting a quick qualitative impression of the enzymatic activity
in colonies using plates containing X-Gal (5-bromo-4-chloro-3-indolyl-ß-
D-galactopyranoside),
and the quantitative assay using
o-nitrophenyl-ß-
D-galactopyranoside
as the chromogenic substrate (
20). In addition,
lacZ-based reporter
systems were already established in other mollicutes, such as
Acholeplasma oculi,
Mycoplasma pulmonis,
Mycoplasma arthritidis,
and
Mycoplasma capricolum (
4,
16,
17). To facilitate cloning
of the promoter fragments and their detection in
E. coli, we
made use of a
lacZ gene devoid of a ribosomal binding site.
With such a reporter, a Shine-Dalgarno sequence must be provided
with the cloned promoter fragment to obtain a functional
lacZ fusion. These requirements are met by the
lacZ gene present
in plasmid pAC5 (
19). The
lacZ gene of pAC5 was amplified using
the primers SH44 (5' TATTTA
AGTACTATAATAAGGGTAACTATTGCCG) and
SH45 (5' GA
ACTAGTACATAATGGATTTCCTTAC). The resulting fragment
was digested with BcuI and ScaI (these sites were introduced
upon PCR and are underlined in the primer sequences) and cloned
between the BcuI and OliI sites of pMT85. The resulting plasmid
was pGP353 (Fig.
1).

Construction and analysis of an ldh-lacZ fusion.
We are interested in carbon metabolism in
M. pneumoniae and
its regulation. These bacteria catabolize a few sugars such
as glucose, fructose, and glycerol via glycolysis but lack a
citric acid cycle (
6,
9). The NADH
+ formed in glycolysis can
be reoxidized by the formation of lactate from pyruvate. The
ldh gene (MPN674) encoding lactate dehydrogenase is one of the
few genes in
M. pneumoniae which is transcribed in the opposite
direction relative to the genes located up- and downstream.
This suggests that
ldh is transcribed monocistronically with
a promoter upstream of the gene. Indeed, a primer extension
assay revealed the presence of a promoter similar to the consensus
sequence of the single
M. pneumoniae 
factor (our unpublished
results;
27). To fuse the
ldh promoter region to the promoterless
lacZ gene present in pGP353, the region from 160 to +81
relative to the
ldh transcription start point was amplified
using the oligonucleotides SH46 (5' A
GAATTCAAACTGCATCGTGGTATCTG)
and SH47 (5' TA
GGATCCGCGTAGAGAAAGCTGGTGC) and cloned between
the EcoRI and BamHI sites of pGP353 (these sites are underlined
in the primer sequences). In the resulting plasmid pGP354 (see
Fig.
2), the
lacZ gene was fused in frame to the 21st codon
of the lactate dehydrogenase gene. The promoter fragment present
in pGP354 contains two internal HindIII sites. These sites were
used to delete the promoter resulting in plasmid pGP364 (see
Fig.
2).
The plasmids pGP353, pGP354, and pGP364 were used to electroporate
M. pneumoniae M129 according to the protocol described previously
(
2). Transformants were selected on plates containing gentamicin
with or without X-Gal. On X-Gal-containing plates, all transformants
that were obtained with pGP354 formed blue colonies, whereas
transformants that were obtained with pGP353 and pGP364 formed
white colonies (see Fig.
3A). This was the first indication
that the promoter fragment was present in the original fragment
and that promoter activity was lost upon deletion of the internal
HindIII fragment. To be unbiased in the further analysis, five
colonies of each transformation were reisolated from plates
that did not contain X-Gal. These colonies were cultivated in
order to obtain DNA for the verification of the presence of
the fusion in the
M. pneumoniae cells and to prepare cell extracts
for the quantitative determination of ß-galactosidase
activity. As shown in Fig.
4, the presence of all three fusions
was demonstrated and the
M. pneumoniae strains were designated
GPM53, GPM54, and GPM64 (transformations with pGP353, pGP354,
and pGP364, respectively). To eliminate positional effects of
transposon integration at random sites in the chromosome, five
individual clones per plasmid were chosen and their ß-galactosidase
activities were determined (
20) in cell extracts that were prepared
as described previously (
6). These individual clones were designated
GPM53/1 through GPM53/5. As shown in Fig.
3B, no ß-galactosidase
was detectable in the five GPM53 clones. This confirms that
the "empty" reporter cloning vector does not confer any expression
of the promoterless
lacZ gene. In contrast, a high activity
was observed in all GPM54 clones containing the
ldh promoter
and Shine-Dalgarno sequence upstream of the
lacZ gene. This
finding demonstrates that the
E. coli lacZ gene can be efficiently
translated in
M. pneumoniae. In the
M. pneumoniae GPM64 clones,
the core of the
ldh promoter is deleted from the fragment upstream
of
lacZ. This resulted in a 7.5-fold reduction of ß-galactosidase
activity compared to that for the GPM54 clones containing the
complete promoter fragment. Even though the transposons inserted
at different positions, the ß-galactosidase activities
driven by the two DNA fragments were quite consistent as indicated
by the standard deviations.
This study demonstrates that
lacZ fusions can be a useful tool
for the analysis of promoter fragments of
M. pneumoniae genes
in vivo. They will help to study regulatory events at the molecular
level using promoter mutants. Moreover, the blue-white screen
can be helpful in the isolation of
trans-acting transposon mutants
that affect the expression of the gene of interest.

ACKNOWLEDGMENTS
We are grateful to Richard Herrmann for the generous gift of
plasmid pMT85 and to Julia Busse for excellent technical assistance.
Stephan Seiler is acknowledged for his help with photographing
of
Mycoplasma colonies.
This work was supported by the Fonds der Chemischen Industrie. S.H. was supported by a personal grant from the Fonds der Chemischen Industrie.

FOOTNOTES
* Corresponding author. Mailing address: Department of General Microbiology, Institute of Microbiology and Genetics, Georg-August University Göttingen, Grisebachstr. 8, D-37077 Göttingen, Germany. Phone: 49-551-393781. Fax: 49-551-393808. E-mail:
jstuelk{at}gwdg.de.


REFERENCES
1 - Benders, G. A., B. C. Powell, and C. A. Hutchison III. 2005. Transcriptional analysis of the conserved ftsZ gene cluster in Mycoplasma genitalium and Mycoplasma pneumoniae. J. Bacteriol. 187:4542-4551.[Abstract/Free Full Text]
2 - Catrein, I., R. Dumke, J. Weiner III, E. Jacobs, and R. Herrmann. 2004. Cross-complementation between the products of the genes P1 and ORF6 of Mycoplasma pneumoniae subtypes 1 and 2. Microbiology 150:3989-4000.[Abstract/Free Full Text]
3 - Chaudhry, R., N. Nisar, B. Hora, S. Reddy, and P. Malhotra. 2004. Expression and immunological characterization of carboxy terminal region of P1 adhesin protein of Mycoplasma pneumoniae. J. Clin. Microbiol. 43:321-325.
4 - Dybvig, K., C. T. French, and L. L. Voelker. 2000. Construction and use of derivatives of transposon Tn4001 that function in Mycoplasma pulmonis and Mycoplasma arthritidis. J. Bacteriol. 182:4343-4347.[Abstract/Free Full Text]
5 - Gil, R., F. J. Silva, J. Peretó, and A. Moya. 2004. Determination of the core of a minimal bacterial gene set. Microbiol. Mol. Biol. Rev. 68:518-537.[Abstract/Free Full Text]
6 - Halbedel, S., C. Hames, and J. Stülke. 2004. In vivo activity of enzymatic and regulatory components of the phosphoenolpyruvate:sugar phosphotransferase system in Mycoplasma pneumoniae. J. Bacteriol. 186:7936-7943.[Abstract/Free Full Text]
7 - Hames, C., S. Halbedel, O. Schilling, and J. Stülke. 2005. MMR: a method for the simultaneous introduction of multiple mutations into the glpK gene of Mycoplasma pneumoniae. Appl. Environ. Microbiol. 71:4097-4100.[Abstract/Free Full Text]
8 - Hedreyda, C. T., K. K. Lee, and D. C. Krause. 1993. Transformation of Mycoplasma pneumoniae with Tn4001 by electroporation. Plasmid 30:170-175.[CrossRef][Medline]
9 - Himmelreich, R., H. Hilbert, H. Plagens, E. Pirkl, B.-C. Li, and R. Herrmann. 1996. Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae. Nucleic Acids Res. 24:4420-4449.[Abstract/Free Full Text]
10 - Hutchison, C. A., III, S. C. Peterson, S. R. Gill, R. T. Cline, O. White, C. M. Fraser, H. O. Smith, and J. C. Venter. 1999. Global transposon mutagenesis and a minimal Mycoplasma genome. Science 286:2165-2169.[Abstract/Free Full Text]
11 - Hyman, H. C., R. Gafny, G. Glaser, and S. Razin. 1988. Promoter of the Mycoplasma pneumoniae rRNA operon. J. Bacteriol. 170:3262-3268.[Abstract/Free Full Text]
12 - Inamine, J. M., S. Loechel, and P. C. Hu. 1988. Analysis of the nucleotide sequence of the P1 operon of Mycoplasma pneumoniae. Gene 73:175-183.[CrossRef][Medline]
13 - Inamine, J. M., K. C. Ho, S. Loechel, and P. C. Hu. 1990. Evidence that UGA is read as tryptophan codon rather than as a stop codon by Mycoplasma pneumoniae, Mycoplasma genitalium, and Mycoplasma gallisepticum. J. Bacteriol. 172:504-506.[Abstract/Free Full Text]
14 - Jacobs, E. 1997. Mycoplasma infections of the human respiratory tract. Wien. Klin. Wochenschr. 109:574-577.[Medline]
15 - Jaffe, J. D., H. C. Berg, and G. M. Church. 2004. Proteogenomic mapping as a complementary method to perform genome annotation. Proteomics 4:59-77.[CrossRef][Medline]
16 - Janis, C., C. Lartigue, J. Frey, H. Wróblewski, F. Thiaucourt, A. Blanchard, and P. Sirand-Pugnet. 2005. Versatile use of oriC plasmids for functional genomics of Mycoplasma capricolum subsp. capricolum. Appl. Environ. Microbiol. 71:2888-2893.[Abstract/Free Full Text]
17 - Knudtson, K. L., and F. C. Minion. 1994. Use of lac gene fusions in the analysis of Acholeplasma upstream gene regulatory sequences. J. Bacteriol. 176:2763-2766.[Abstract/Free Full Text]
18 - Lind, K. 1983. Manifestations and complications of Mycoplasma pneumoniae disease: a review. Yale J. Biol. Med. 56:461-468.[Medline]
19 - Martin-Verstraete, I., M. Débarbouillé, A. Klier, and G. Rapoport. 1992. Mutagenesis of the Bacillus subtilis "-12, -24" promoter of the levanase operon and evidence for the existence of an upstream activating sequence. J. Mol. Biol. 226:85-99.[CrossRef][Medline]
20 - Miller, J. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
21 - Regula, J. T., B. Ueberle, G. Boguth, A. Görg, M. Schnölzer, R. Herrmann, and R. Frank. 2000. Towards a two-dimensional proteome map of Mycoplasma pneumoniae. Electrophoresis 21:3765-3780.[CrossRef][Medline]
22 - Rouch, D. A., M. E. Byrne, Y. C. Kong, and R. A. Skurray. 1987. The aac-aphD gentamicin and kanamycin resistance determinant of Tn4001 from Staphylococcus aureus: expression and nucleotide sequence analysis. J. Gen. Microbiol. 133:3039-3052.[Abstract/Free Full Text]
23 - Ueberle, B., R. Frank, and R. Herrmann. 2002. The proteome of the bacterium Mycoplasma pneumoniae: comparing predicted open reading frames to identified gene products. Proteomics 2:754-764.[CrossRef][Medline]
24 - Waites, K. B., and D. F. Talkington. 2004. Mycoplasma pneumoniae and its role as human pathogen. Clin. Microbiol. Rev. 17:697-728.[Abstract/Free Full Text]
25 - Waldo, R. H., III, P. L. Popham, C. E. Romero-Arroyo, E. A. Mothershed, K. K. Lee, and D. C. Krause. 1999. Transcriptional analysis of the hmw gene cluster of Mycoplasma pneumoniae. J. Bacteriol. 181:4978-4985.[Abstract/Free Full Text]
26 - Waldo, R. H., III, J. L. Jordan, and D. C. Krause. 2005. Identification and complementation of a mutation associated with loss of Mycoplasma pneumoniae virulence-specific proteins B and C. J. Bacteriol. 187:747-751.[Abstract/Free Full Text]
27 - Weiner, J., III, R. Herrmann, and G. F. Browning. 2000. Transcription in Mycoplasma pneumoniae. Nucleic Acids Res. 28:4488-4496.[Abstract/Free Full Text]
28 - Weiner, J., III, C. U. Zimmerman, H. W. H. Göhlmann, and R. Herrmann. 2003. Transcription profiles of the bacterium Mycoplasma pneumoniae grown at different temperatures. Nucleic Acids Res. 31:6306-6320.[Abstract/Free Full Text]
29 - Willby, M. J., and D. C. Krause. 2002. Characterization of a Mycoplasma pneumoniae hmw3 mutant: implications for attachment organelle assembly. J. Bacteriol. 184:3061-3068.[Abstract/Free Full Text]
30 - Zimmerman, C.-U., and R. Herrmann. 2005. Synthesis of a small, cysteine-rich, 29 amino acids long peptide in Mycoplasma pneumoniae. FEMS Microbiol. Lett. 253:315-321 [Online.] doi:10.1016/j.femsle.2005.09.054.[CrossRef][Medline]
Applied and Environmental Microbiology, February 2006, p. 1696-1699, Vol. 72, No. 2
0099-2240/06/$08.00+0 doi:10.1128/AEM.72.2.1696-1699.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Lluch-Senar, M., Vallmitjana, M., Querol, E., Pinol, J.
(2007). A new promoterless reporter vector reveals antisense transcription in Mycoplasma genitalium. Microbiology
153: 2743-2752
[Abstract]
[Full Text]